Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2002
12/25/2002CN1386850A Polypeptide-glyceraldehyde-3-phosphate dehydrogenase-8.91 and polyncleotide for coding it
12/25/2002CN1386849A Polypeptide-Ser/Thr kinase protein-51.37 and polynucleotide for coding it
12/25/2002CN1386743A Efficient antifungal momordic chitinase gene
12/25/2002CN1097092C Fructoamino-acid-oxidase and its producing method
12/24/2002US6498239 Sterol glycosyl transferases
12/24/2002US6498234 Compounds
12/24/2002US6498026 Variant galactose oxidase, nucleic acid encoding same, and methods of using same
12/24/2002US6498019 Lecithin-cholesterol acyltransferase protein
12/24/2002US6497877 Plasminogen activator as an anti-inflammatory agent
12/24/2002US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/24/2002CA2087261C Purification directed cloning of peptides
12/19/2002WO2002101093A1 Method of determining dna base sequence
12/19/2002WO2002101078A2 Cellulases, nucleic acids encoding them and methods for making and using them
12/19/2002WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002WO2002101059A2 Transgenic plants synthesising high amylose starch
12/19/2002WO2002101056A2 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/19/2002WO2002101053A1 Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
12/19/2002WO2002101052A2 Salutaridinol 7-o-acetyltransferase and derivatives thereof
12/19/2002WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002WO2002101033A1 A process of isolation and utilization of rice bran lipase
12/19/2002WO2002101032A1 Mutant rna polymerases
12/19/2002WO2002101003A2 Stereoselective preparation of cyclic l-amino acids
12/19/2002WO2002100998A2 Method for generating diversity
12/19/2002WO2002100896A2 Method for diagnosing cancer susceptibility
12/19/2002WO2002100884A2 Cloned mammalian polyamine oxidase
12/19/2002WO2002100628A1 Preservation of biological materials using fiber-forming techniques
12/19/2002WO2002100337A2 Antithrombotic thrombin variants
12/19/2002WO2002100199A2 Modifying nicotine and nitrosamine levels in tobacco
12/19/2002WO2002070678A3 Regulation of human serine/threonine protein kinase
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002WO2002068462A3 Internal standard for electrophoretic and chromatographic separation processes
12/19/2002WO2002066624A3 Novel human protease and polynucleotides encoding the same
12/19/2002WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002WO2002061055A3 Methods for regulating the kinase domain of ephb2
12/19/2002WO2002055711A3 Method for the production of pantothenic acid by fermentation
12/19/2002WO2002048334A3 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
12/19/2002WO2002044360A3 Modified arginine deiminase
12/19/2002WO2002039966A3 Enzymatic coloring agents
12/19/2002WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002WO2002012338A3 Screening method
12/19/2002WO2002005836A3 Stimulation of bone growth with thrombin peptide derivatives
12/19/2002WO2001075087A3 Subtilisin variants
12/19/2002WO2001075077A8 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
12/19/2002WO2001073060A9 18221, dual specificity phosphatase and uses thereof
12/19/2002WO2001073050A9 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
12/19/2002WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002US20020194644 Method for increasing stress-resistance to a plant
12/19/2002US20020194642 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
12/19/2002US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002US20020194634 Insect control system
12/19/2002US20020194629 Treatment of Staphylococcus infections
12/19/2002US20020194625 Transgenic animals expressing heparanase and its uses
12/19/2002US20020193583 Novel human proteases and polynucleotides encoding the same
12/19/2002US20020193581 Allele for use in the diagnosis and treatment of schizophrenia and psychological disorders
12/19/2002US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002US20020193579 Non-nucleotide containing enzymatic nucleic acid
12/19/2002US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002US20020193316 Caloporoside derivatives, methods of their preparation and use
12/19/2002US20020193303 58860, a human cholesteryl ester hydrolase and uses therefor
12/19/2002US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002US20020193296 Vaccines; therapy; prophylaxis
12/19/2002US20020193275 Low-density compositions and particulates including same
12/19/2002US20020193272 Cellulase for use in industrial processes
12/19/2002US20020192823 Expression vector for use as tool in gene therapy
12/19/2002US20020192819 Generation of preferential nucleotide sequences; obtain nucleotide sequences, incubate with vector, ligate, recover sequences
12/19/2002US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002US20020192795 Cathepsin for use in the treatment of bone and cancer disorders
12/19/2002US20020192794 Purification of plasmin; obtain sample of plasminogen, incubate with activator, recover plasmin
12/19/2002US20020192793 Isolation of the biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
12/19/2002US20020192792 Laccase mutants
12/19/2002US20020192791 Genration of phytase for use in animal feeds; obtain genetically engineered yeast, express vector, recover phytase
12/19/2002US20020192790 Polynucleotides for use in the treatment and diagnosis of cancer and autoimmune diseases
12/19/2002US20020192789 Novel enterokinase cleavage sequences
12/19/2002US20020192788 Preferential kinase for use in generation of nucleoside monophosphates
12/19/2002US20020192787 Polypeptide for use in the diagnosis, treatment, and prevention of cancer and developmental defects
12/19/2002US20020192786 Nucleotide sequences coding polypeptides for use in the generation of amino acid compounds
12/19/2002US20020192784 Nucleotide sequences coding polypeptide for use in the treatment of bone and connective tissue disorders
12/19/2002US20020192783 (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes
12/19/2002US20020192782 Enzymatic polypeptide for use in the generation of pharmeceuticals
12/19/2002US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002US20020192775 Matrix granule
12/19/2002US20020192771 Beta -fructofuranosidase and its gene, method of isolating beta -fructofuranosidase gene, system for producing beta -fructofuranosidase, and beta -fructofuranosidase variant
12/19/2002US20020192767 Biosynthesis of polyketide synthase substrates
12/19/2002US20020192766 Esterase free enzymes
12/19/2002US20020192756 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
12/19/2002US20020192754 Generation of preferential serine proteases; obtain genetically engineered prokaryotic cell, transform with gene expressing serine proteases, recover serine proteases
12/19/2002US20020192752 Compositions and methods for the treatment of immune related diseases
12/19/2002US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002US20020192747 Generation of galactose oxidase; obtain genetically engineered yeast, induce enzymatic gene expression, recover galactose oxidase
12/19/2002US20020192746 Generation preferential nucleotide sequences; obtan nutrient broth, incubate with microorganism, induce production of purine nucleotides, recover nucleotides
12/19/2002US20020192723 Protein for use in the diagnosis and treatment of autoimmune disease
12/19/2002US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002US20020192694 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of depression, anxiety, nervous system, obesity, high blood pressure and connective tissue disorders
12/19/2002US20020192674 Nucleotide sequences coding protein for use in the fermentation of amino acids
12/19/2002US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002US20020192663 Thermostable polymerases having altered fidelity and methods of identifying and using same